How big is Celldex Therapeutics, Inc.?

Jun 22 2025 05:59 PM IST
share
Share Via
As of Jun 18, Celldex Therapeutics, Inc. has a market capitalization of $1.33 billion, with net sales of $7.56 million and a net profit of -$178.85 million over the last four quarters.
As of Jun 18, Celldex Therapeutics, Inc. has a market capitalization of 1,331.87 million, categorizing it as a Small Cap company.

As of Jun 18, the sum of net sales for the latest four quarters is 7.56 million, while the sum of net profit for the same period is -178.85 million.

As of Dec 24, the reporting period shows shareholder's funds of 747.00 million and total assets of 792.34 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News